AI personal assistants are now negotiating healthcare bills and booking appointments on behalf of consumers, marking a shift in how patients interact with the healthcare system. The development comes as telehealth vendors report AI agents like Instinct appearing in customer service channels, while a new startup called Ferry Health emerged from stealth with $9 million to build a dedicated health-focused AI assistant.
AI agents are reaching healthcare's front door
Steve Hind, co-founder of Lorikeet, said some telehealth customers are seeing Instinct show up in customer service emails, negotiating discounts for users. The AI demonstrates what Hind described as limitless patience when searching for available discounts - a task that would deter human users. "If you use an AI assistant to book a dinner you actually plan to attend, I don't see why that's different from a wealthy person having an executive assistant do the same thing," one VC told Inc, after his Instinct assistant secured a hard-to-get restaurant reservation by hitting Resy's API roughly 200 times an hour.
Ferry Health launched Thursday with funding to build an AI assistant that makes phone calls to provider groups until it schedules an appointment. The company said over 1 million patients already have access through partnerships with health systems, health plans, and care navigation platforms, and expects that number to grow 5x by year-end. The question now is what happens when these agents turn their attention to negotiating medical bills, reading through pricing files, and consuming information across the internet on behalf of patients.
Oscar Health pivots to consumer marketplace with Lucie
Oscar Health held its Investor Day Wednesday, positioning its core ACA insurance business as a maturing asset while unveiling Lucie as its consumer marketplace brand. Oscar expects the ACA market to grow, particularly through CHOICE plans which it projects will reach 2.5 million lives by 2029. But the company said Lucie won't contribute to its 2029 financial targets - a pattern reminiscent of previous efforts to commercialize its platform business.
The messaging grew more confusing Thursday when Adweek ran an interview describing Oscar Health as the parent of three brands: Oscar Insurance, Lucie, and Trove, an in-house health insurance agency. Trove received no mention during Wednesday's Investor Day presentation. Oscar appears to be a company searching for its second act, with an impressive ACA insurance business that needs a new growth narrative to drive investor excitement.
OpenEvidence takes quiet funding at lower valuation, enters drug development
Forbes reported that OpenEvidence quietly raised $250 million last week at a $15 billion valuation - a figure that sits between its January raise at $12 billion and a reported $20 billion offer it considered in July. The company did not issue a press release or make CEO Daniel Nadler available for interviews, a departure from its previous funding announcement.
More surprisingly, OpenEvidence said it will enter the drug development space, targeting oncology therapies for rare diseases with its first clinical trial expected before year-end. "We are not going to compete with Lilly or Pfizer to do 10,000 patient nation-scale trials. We're going to go after the stuff that they are not doing, and maybe can't do, because it doesn't work with their business model," Nadler told Forbes. The shift suggests OpenEvidence may be hitting a ceiling in its core clinical AI business and searching for new revenue narratives.
Alternative plan design funding surges
Angle Health, an AI-native level-funded health plan for employers, raised $200 million in capital plus $400 million in a secondary offering, roughly doubling its business since its last raise. Thatch, a platform for CHOICE plans, raised funding from strategic partners including Eli Lilly, ADP Ventures, and Paychex, reporting approximately 5,000 employers on its platform out of an estimated 12,000 employers offering CHOICE plans industry-wide.
Nara Health raised $10 million after helping a small employer move from a level-funded plan to a self-insured design. The employer reported benefits costs down 55% year-over-year compared to a 27% proposed renewal increase on the previous plan. CMS also expanded its ACCESS model this week, adding heart failure, COPD, substance use disorder, tobacco cessation, and additional MSK conditions to the program, which seeks to manage chronic disease in Original Medicare through deflationary payment rates.
Why this matters for customer support, healthcare, and sales professionals
AI agents negotiating with customer service teams are no longer a theoretical concern - telehealth vendors are already seeing them in action. For customer support professionals, this means preparing for interactions where the counterparty has unlimited patience, access to pricing data, and the ability to systematically exhaust every available discount. Sales teams selling into employer benefits should note the momentum behind alternative plan designs like level-funded and CHOICE plans, as employers seek relief from cost increases. The funding flowing to Angle Health, Thatch, and Nara Health signals where employer demand is heading. For healthcare professionals, the New York Times reported discussions within the administration about paying AI doctors 60% to 80% of what human doctors earn - a reimbursement framework that could reshape clinical roles faster than many expect.
Your membership also unlocks:
